Synthetic anti-inflammatory glucocorticoid that displays chemopreventive activity. Prevents formation of lung adenomas and adenocarcinomas in mice following inhalation or oral administration. Reverses DNA hypomethylation and modulates expression of cancer related genes.
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
All Tocris products are intended for laboratory research use only.
Budesonide. A review of its pharmacological properties and therapeutic efficacy in inflammatory bowel disease.
Spencer et al.
Modulation by budesonide of DNA methylation and mRNA expression in mouse lung tumors.
Pereira et al.
The citations listed below are publications that use Tocris products. Selected citations for Budesonide include:
Showing Results 1 - 2 of 2